Rakovina Therapeutics Inc.
RKV.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -143.33% | -149.36% | -94.14% | -52.89% | -29.19% |
| Total Depreciation and Amortization | -3.01% | -3.15% | -3.31% | -1.21% | -0.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 258.68% | 63.82% | 93.85% | 16.91% | 39.90% |
| Change in Net Operating Assets | -304.93% | -211.50% | -302.19% | -2,584.18% | 182.20% |
| Cash from Operations | -178.82% | -391.18% | -154.78% | -102.32% | -26.39% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 228.71% | 304.59% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -226.24% | -82.43% | -67.02% | -67.02% | 28.37% |
| Cash from Financing | 292.23% | 373.16% | 227.15% | 227.15% | 34.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 203.54% | 209.62% | 83.54% | 282.61% | -5.73% |